In the same work, Naka et al. showed that SS cell lines, similarly to SS clinical samples, contain a subpopulation of cells characterized by high levels of the pluripotency factors SOX2, OCT4, and NANOG and that exhibit in vitro self-renewal ability and in vivo tumorigenicity following xenografting (54). The gene discussed is NANOG; the disease is synovial sarcoma.